Chinese bioplastics maker Bluepha bags $235m in Series B

Chinese bioplastics maker Bluepha bags $235m in Series B

Source: Bluepha

10 January, 2022

bioplastics Bluepha China State Owned Enterprises Mixed Ownership Reform Fund Genesis Capital synthetic biology

Printed by Unregistered user on Mon, 29 Dec 2025 18:36:48 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

China Digest: Bluepha nets $66m; Space Transportation closes $46m funding

Venture Capital

Chinese AI-based drug maker Xbiome bags nearly $100m in Series B round

Read more from Greater China

Demand for China’s lithium batteries may fall in 2026 as EV sales slow

Chinese firm LandSpace’s reusable rockets put Musk’s SpaceX on alert